Translational Research Inst. for Metabolism and Diabetes is a clinical research site located in Orlando, Florida, United States 32804.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Translational Research Inst. for Metabolism and Diabetes has participated in 1 clinical trials.
Therapeutic areas: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.
Sponsors: Rhythm Pharmaceuticals, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Translational Research Inst. for Metabolism and Diabetes has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Translational Research Inst. for Metabolism and Diabetes has 1 clinical trials on record. Their work covers Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.
Translational Research Inst. for Metabolism and Diabetes has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.